2 unknown, 1 completed, 1 withdrawn. 1 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Alzheimer Disease 3: new trials by email Literature Review of Alzheimer Disease 3 trials Research Report on Alzheimer Disease 3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Improvement Effect of Lacosamide and Levetiracetam on Cognitive in Alzheimer's Disease Patients With Epilepsy Lacosamide 100 mg, Levetiracetam 250mg - Alzheimer Disease 3, Epilepsy | Phase 4 | Unknown | Xiangya Hospital of Central South University | 140 | 2023-07-05 | 2023-08-04 |
| Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease APH-1105, Placebo - Dementia, Alzheimer Disease 1 | Phase 2 | Unknown | Aphios | 60 | 2023-06-01 | 2021-07-27 |
| A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study) Spectris™ AD - Active, Spectris™ AD - Sham - Alzheimer Disease, Alzheimer Disease 1 | Not applicable | Completed | Cognito Therapeutics, Inc. | 673 | 2022-12-13 | 2026-09-09 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease No Intervention - Alzheimer Disease, Alzheimer Disease 1 | Withdrawn | ProgenaBiome | 2020-03-02 | 2025-06-05 |
Alzheimer Disease (4) · Alzheimer disease, familial, type 3 (4) · Alzheimer disease type 1 (3) · Alzheimer disease type 2 (3) · Alzheimer Disease 10 (2) · Alzheimer Disease 11 (2) · Alzheimer Disease 12 (2) · Alzheimer Disease 13 (2) · Alzheimer Disease 14 (2) · Alzheimer Disease 15 (2) · Alzheimer Disease 16 (2) · Alzheimer Disease 5 (2) · Alzheimer Disease 6 (2) · Alzheimer Disease 7 (2) · Alzheimer Disease 8 (2)
Brain Diseases (4) · Central Nervous System Diseases (4) · Mental Disorders (4) · Nervous System Diseases (4) · Neurocognitive Disorders (4) · Neurodegenerative Diseases (4) · Tauopathies (4) · Dementia (2) · Cognition Disorders (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1)
Lacosamide (1) · Levetiracetam (1)
Aphios (1) · Cognito Therapeutics, Inc. (1) · ProgenaBiome (1) · Xiangya Hospital of Central South University (1)
United States (2) · China (1)